Calcium influx through store-operated calcium release-activated calcium channels (CRAC) is required for T cell activation, cytokine synthesis, and proliferation. The CD95 (Apo-1͞Fas) receptor plays a role in self-tolerance and tumor immune escape, and it mediates apoptosis in activated T cells. In this paper we show that CD95-stimulation blocks CRAC and Ca 2؉ influx in lymphocytes through the activation of acidic sphingomyelinase (ASM) and ceramide release. The block of Ca 2؉ entry is lacking in CD95-defective lpr lymphocytes as well as in ASM-defective cells and can be restored by retransfection of ASM. C2 ceramide, C6 ceramide, and sphingosine block CRAC reversibly, whereas the inactive dihydroceramide has no effect. CD95-stimulation or the addition of ceramide prevents store-operated Ca 2؉ The CD95-receptor induces apoptosis in lymphocytes and is critically involved in the maintenance of self-tolerance (reviewed in ref. 5). Expression of the CD95 ligand (CD95L) can create immune privileged sites (6, 7), and malignant tumors may escape from the immune attack by expressing high levels of CD95L (8, 9) .
influx (2) . In T cells, a lasting Ca 2ϩ rise Ͼ500 nM is required to induce IL-2 synthesis (3). The inhibition of Ca 2ϩ -dependent signaling pathways with cyclosporin or ion channel blockers completely suppresses T cell activation (reviewed in ref. 4) .
The CD95-receptor induces apoptosis in lymphocytes and is critically involved in the maintenance of self-tolerance (reviewed in ref. 5) . Expression of the CD95 ligand (CD95L) can create immune privileged sites (6, 7) , and malignant tumors may escape from the immune attack by expressing high levels of CD95L (8, 9) .
However, CD95 may have additional functions apart from lymphocyte apoptosis. First, freshly activated T lymphocytes express CD95 but are resistant to CD95-mediated apoptosis (10, 11) . Second, in tumor patients, defective lymphocyte function rather than apoptotic deletion has been observed (12, 13) . Third, mice inoculated with a CD95L-expressing tumor develop severe CD95-mediated defects in lymphocyte function (14) . Fourth, the knockout of CD95-activated signaling molecules required for apoptosis does not, in contrast to CD95-knockout, result in lymphoproliferative disease (15, 16) . Thus, apoptosis may not represent the only function of CD95 in immune tolerance.
Materials and Methods
Cells. Jurkat T cells, Niemann-Pick Disease type A (NPDA), Daudi, and JY B cells were maintained in RPMI medium 1640, and LN18 and LN229 glioblastoma were maintained in DMEM (17) . The stimulating monoclonal mouse anti-human CD95 (CH11; Upstate Biotechnology, Lake Placid, NY) was added at 100 ng͞ml. Apoptosis was assayed by nuclear fragmentation (Hoe33342, propidium iodide or SYTO 16; Molecular Probes) or FITC-annexin flow cytometry. Peripheral T lymphoblasts were prepared by using a Ficoll gradient, purified with nylon wool columns (Ͼ90% CD3 ϩ ), and stimulated with 1 g͞ml phythaemaglutinin (PHA) (24 h) plus 2.5 units͞ml IL-2 (4-6 days). Thymocytes were prepared from homozygous C57͞Bl6 lpr-and gld mice (ages 10-15 weeks). Transient transfection of NPDA cells was performed by electroporation with an expression vector encoding acidic sphingomyelinase (ASM) (pJK-asm, 15 g͞ml) and a Myc-tagged single chain (18) . Twelve hours after electroporation viable cells were purified by Ficoll gradient centrifugation and cultured for an additional 24 h. After 36 h, Myc presented on the cell surface was stained with a monoclonal anti-Myc-antibody (9E10; American Type Culture Collection, Bethesda, MD) and a phycoerythrin-conjugated secondary antibody (18) [Ca 2ϩ ] i was performed in single cells after loading at 37°C with 4.5 M of fura-red-acetoxymethyl ester for 30 min and 0.5 M of fluo-3-acetoxymethyl ester for 10 min in the presence of 0.015% pluronic acid (Molecular Probes). Calibration was performed for each experimental condition by using 10 M ionomycin and varying external Ca 2ϩ concentrations. Ca 2ϩ concentrations were approximated as described (19) and confirmed with fura-2 fluorescence microscopy. For digital ratiometric fluorescence microscopy, cells were loaded at 37°C with fura-2-acetoxymethyl ester (Molecular Probes) on glass coverslips coated with poly-L-lysine. Digital video imaging ratios (340:380 nm excitation and 510 nm emission) were obtained on a Zeiss Axiovert 135 fluorescence microscope at 34°C, recorded with an intensified charge-coupled device camera, and digitized with an Axon image lightning system (Axon Instruments, Foster City, CA). In situ calibration was performed as described above.
IL-2 Assay. Intracellular IL-2 content was analyzed by FACS. Cytokine release was blocked by monensin (1 M). Cells were stimulated with 50 g͞ml PHA and 100 nM phorbol 12-myristate 13-acetate for 5 h, fixed, permeabilized (Cytofix͞ Cytoperm, PharMingen), and stained with a FITC-conjugated rat anti-human IL-2 IgG2a or matched isotype control antibody (1.5 g͞ml, PharMingen). Apoptotic cells were excluded by gating.
Gel Mobility Shift Assays of NFAT. Cells were stimulated with 1 M of thapsigargin (TG) for 20 min; 100 ng͞ml CD95-antibody was added at 1 h, 400 nM cyclosporin A at 2 h before, and 100 M C2 ceramide simultaneously with TG. Cells were then incubated for 1 h in 10 mM Hepes, pH 7.9͞10 mM KCl͞0.01 mM EDTA͞0.01 mM EGTA͞20 mM PMSF͞1 mM DTT (buffer A) at 0°C. Nonidet P-40 (0.6%) was added, nuclei were pelleted and washed in buffer A, and nuclear proteins were eluted for 1 h in 20 mM Hepes, pH 7.9͞400 mM KCl͞0.1 mM EDTA͞20 mM PMSF͞1 mM DTT͞10% glycerol. DNA consensus nucleotides (NFATc: GGAAAA, and AP-1: TGACTCA) (Santa Cruz Biotechnology) matching the NFAT binding sequence in the IL-2 promoter were 32 P-labeled with T4 polynucleotide kinase (Promega). Gel mobility shifts were electrophoretically separated by PAGE in 0.5ϫ TBE buffer (90 mM Tris͞64.6 mM boric acid͞2.5 mM EDTA, pH 8. ) were stimulated with 100 ng͞ml CH11 antibody. Lipids were extracted in CHCl 3 :CH 3 OH:1M HCl (100:100:1), dried, dissolved, and 40 g͞ml purified diacylglycerol kinase, 10 Ci per sample [␥-32 P]ATP, and 5 mM ATP were added. After 30 min at 20°C, the reaction was stopped by the addition of 1 ml of CHCl 3 :CH 3 OH:1M HCl (100:100:1), 170 l of extracellular solution, and 30 l of 100 mM EDTA. The lower organic phase was dried and resuspended in CHCl 3 :CH 3 OH (1:1), and lipids were separated by TLC with CHCl 3 :CH 3 OH:acetic acid (13:3:1) as solvent. Spots were visualized by autoradiography, cut out, and analyzed by liquid scintillation counting. Uptake of extracellularly applied 14 C-labeled C2 ceramide (1 Ci per sample; American Radiolabeled Chemicals Inc., St. Louis) was studied by using 10 6 cells in 1 ml of extracellular solution containing 0.1% BSA. After a 5-min incubation at 20°C, the cells were washed three times in fresh vials and activity was counted.
Results

CD95-Stimulation Blocks Ca 2؉ Entry in Human T Lymphocytes.
To analyze CD95 effects on Ca 2ϩ signals in human peripheral T cells, [Ca 2ϩ ] i was measured in single lymphoblasts (Fig. 1) . After 24 h of CD95-stimulation, store-operated Ca 2ϩ entry was inhibited in viable cells ( Fig. 1 C and D) . TG was used to activate store-operated Ca 2ϩ entry, because it specifically blocks the endoplasmic Ca 2ϩ pump leading to maximal activation of storeoperated Ca 2ϩ channels (20) . Even resting calcium levels were slightly reduced following CD95 stimulation (not shown). In contrast to store-operated Ca 2ϩ entry, permeabilizing the cells with 10 M ionomycin increased [Ca 2ϩ ] i whether CD95 was triggered or not ( Fig. 1 E and F) .
We then investigated the time course of Ca 2ϩ entry after CD95 stimulation. The block of TG-induced Ca 2ϩ influx following CD95 stimulation was already seen after 1 h in human peripheral T lymphoblasts and Jurkat T cells (Fig. 1G ) and lasted for Ͼ18 h. The same result was obtained when Ca 2ϩ influx was stimulated via the TCR (10 g͞ml PHA, not shown). The -free conditions after the application of TG was in good agreement with previous studies (21) and was not altered by CD95, excluding an effect on the Ca 2ϩ content of intracellular stores or on the ability of TG to empty stores (Fig. 1G ).
Store-Operated Ca 2؉ Channels Are Blocked by CD95 Stimulation.
Because various factors like membrane depolarization can affect Ca 2ϩ entry, current through CRAC was recorded in voltageclamped single T cells by using the patch-clamp technique. The cytoplasm was dialyzed with EGTA after breaking into the whole-cell configuration. In control cells a typical, inwardly rectifying Ca 2ϩ current developed because of the depletion of Ca 2ϩ stores and the subsequent opening of store-operated CRAC ( Fig. 2A) . When cells were prestimulated with anti-CD95 for 1.5 h, development of the Ca 2ϩ current was blocked (Fig. 2 A) . Acute addition of 100 ng͞ml ␣-CD95 did not inhibit the current (not shown).
Ceramide and Sphingosine Block CRAC. During CD95 stimulation the lipid messenger ceramide is released by activated ASM (35) . Ceramide can then be further metabolized to sphingosine. Acute addition of C2 ceramide, C6 ceramide, or sphingosine reversibly and dose-dependently blocked Ca 2ϩ currents through CRAC in whole-cell patch-clamp recordings and Ca 2ϩ entry ( Fig. 2 B-E) , whereas the inactive analogue dihydro-C2-ceramide had no effect (not shown). Polarizing the membrane voltage with 10 M valinomycin did not affect inhibition by sphingolipids (Fig. 2E ) or CD95 stimulation (not shown). Preincubation with C2 ceramide or sphingosine for up to 1 h also inhibited Ca 2ϩ entry (not shown). Ceramide levels after a 5-min incubation with 100 M ceramide͞BSA corresponded well to the amount of ceramide generated 40-120 min after CD95 stimulation, in agreement with previously published results ( Fig. 2F; refs. 22 and 23) . We conclude that ASM metabolites mimic CD95-mediated inhibition of Ca 2ϩ influx. , n ϭ 6 ). Whole-cell current was normalized to maximal Ca 2ϩ current at Ϫ40 mV (see Fig. 2 A) . Similar results were obtained with C6 ceramide, yielding 55% inhibition at 10 M (not shown, n ϭ 2). All solutions contained 0.1% BSA. (F) Cellular ceramide levels after CD95 stimulation with 100 ng͞ml ␣-CD95 in Jurkat T lymphocytes. Ceramide was measured with the diacylglycerol kinase assay. The ceramide spots were identified in TLC with autoradiography (Lower) and cut out, and activity was counted (filled bars). The open bars indicate binding of externally applied 14 C-labeled C2 ceramide to 10 6 Jurkat cells (5 min). All solutions contained 0.1% BSA. Representative for three experiments.
Block of Ca 2؉ Signals Requires CD95 and ASM. Human Jurkat T cells and murine thymocytes were then cocultured with CD95L-expressing glioblastoma cells for 1.5 h, resulting in a block of store-operated Ca 2ϩ entry (Fig. 3A) . Neutralizing CD95L by a CD95-Fc-fusion protein (Alexis Biotech, San Diego) prevented this block of Ca 2ϩ entry (Fig. 3B) , and coculture with CD95L-negative human foreskin fibroblasts did not inhibit Ca 2ϩ entry (not shown). To prove the requirement of CD95 for this effect in a genetic model, CD95 or CD95L-deficient thymocytes from lpr or gld mice were employed. CD95L-deficient gld mice served as controls because they develop the same lymphoproliferative disease as lpr mice. CD95L ϩ tumor cells blocked Ca 2ϩ entry in thymocytes from CD95L-defective gld mice (Fig. 3C) as well as wild-type mice (not shown). In contrast, Ca 2ϩ entry was not blocked in CD95-defective lpr thymocytes (Fig. 3C) , demonstrating that CD95L blocks Ca 2ϩ influx in T cells through CD95. Next, we studied the involvement of ASM in CD95-mediated Ca 2ϩ block by using NPDA B lymphoblasts that were lacking functional ASM. The ASM defect reversed the effect of CD95 on store-operated Ca 2ϩ influx, whereas in wild-type B cells (JY or Daudi), Ca 2ϩ entry was inhibited by CD95 (Fig. 3D) . CD95 stimulation even increased TG-induced Ca 2ϩ entry in NPDA cells (Fig. 3D) . This result indicates the existence of CD95 signals in B cells that propagate Ca 2ϩ influx, but they are normally masked by ASM-mediated inhibition of CRAC. Transfection of NPDA cells with an expression vector for ASM rescued the CD95 effect on Ca 2ϩ signals in NPDA cells (Fig. 3D ). These data demonstrate that ASM is required for CD95-mediated block of Ca 2ϩ entry.
Block of Ca 2؉ -Dependent Lymphocyte Activation Signals. Activity of NFAT is known to be involved in the TCR-dependent IL-2 synthesis (24) . TG strongly activated NFAT binding to the IL-2 promoter in nuclear extracts (Fig. 4A) . CD95-AB, ceramide, or the immunosuppressant drug cyclosporin A blocked this binding activity (Fig. 4A) . To distinguish between CD95-induced cell death and effects on lymphocyte function, we measured IL-2 synthesis in single apoptosis-resistant Jurkat T cells. Increased IL-2 synthesis was observed after TCR-stimulation (Fig. 4B) . Upon a low-dose CD95-stimulation for 18 h (100 ng͞ml CH11), 50% of the T cells survived. In this apoptosis-resistant population, IL-2 synthesis was blocked (Fig. 4B) . As shown in Fig. 4B , the calcium ionophore ionomycin (10 M) completely restored TCRinduced IL-2 synthesis despite CD95 stimulation. These results demonstrate that the block of Ca 2ϩ channels via CD95 inhibits IL-2 transcription.
Discussion
In this paper, we describe block of store-operated Ca 2ϩ entry through CRAC as a function of the CD95 receptor in lymphocytes. The block of Ca 2ϩ entry by either CD95 stimulation or ASM-released lipid metabolites inhibits T cell activation signals, including Ca 2ϩ influx, NFAT activation, and IL-2 production. Thus, CD95 represents a receptor negatively regulating T cell Ca 2ϩ channels. Block of Ca 2ϩ -dependent T cell signals might be significant for understanding CD95-mediated immune suppression. Manipulating CD95-induced suppression of T cell activation could be beneficial for therapeutic strategies to prevent tumor immune evasion, to increase the efficacy of antitumor vaccines, and to aim at specific immune suppression in organ transplantation.
Store-operated or calcium-release-activated Ca 2ϩ channels are opened by any manipulation reducing the endoplasmic reticulum Ca 2ϩ content, i.e., by using either inositoltrisphosphate͞Ca 2ϩ chelators or blockers of the Ca 2ϩ reuptake into the endoplasmic reticulum (2, 25) . In this paper, Ca 2ϩ influx and Ca 2ϩ -dependent signals were blocked after CD95-stimulation whether we activated store-operated Ca 2ϩ influx by stimulation of the TCR, by direct depletion of stores with TG, or with intracellular EGTA. TG has been shown to activate the same CRAC as TCR-stimulation by antigen (26) . We used TG to bypass TCR signals upstream of the endoplasmic Ca 2ϩ store and, thus, to specifically assay the influence of CD95 stimulation on CRAC.
Several signals inhibiting store-operated Ca 2ϩ entry have been described. In B lymphocytes, negative signaling through Fc␥RII receptors involves inhibition of Ca 2ϩ influx (27) . CRAC is inhibited in mast cells via protein kinase C (28) . Inhibition of Ca 2ϩ entry by sphingomyelinase products has been observed in T cells, mast cells, and thyroid cells (29) (30) (31) . Mathes et al. (30) analyzed in detail the effects of different sphingolipids on mast cells. The slow accumulation of lipids in the membrane assayed by membrane capacitance corresponded well to the time course and degree of inhibition. In mast cells, the ceramide metabolite sphingosine inhibited CRAC more potently and faster than C2 ceramide, and nerve growth factor inhibited CRAC currents rapidly (30) . In a thyroid cell line, tumor necrosis-factor ␣, bacterial sphingomyelinase, and C2 as well as C6 ceramide inhibited Ca 2ϩ influx (31) .
In our study we genetically manipulated ASM, showing that this enzyme is indispensable for inhibition of CRAC by CD95. Like in mast cells, sphingosine that can be cleaved from ceramide by ceramidase was more potent than C2 ceramide. In contrast to mast cells, but similar to thyroid cells, C6 ceramide inhibited lymphocyte CRAC (30, 31) . Whereas nerve growth factor acutely inhibited CRAC in mast cells (30) , CD95 in lymphocytes had to be stimulated for 1 h, possibly indicating a slower accumulation of sphingolipids. Interestingly, the metabolite sphingosine-phosphate, which stimulates proliferative EDG receptors, does not inhibit CRAC in mast cells (30) . To pinpoint the exact lipid metabolite(s) downstream of ASM or their putative target(s), genetic manipulation of ceramidase as well as identification of the CRAC protein will be required.
Previously, CD95 has been suggested to inhibit TCR signals, because TCR-induced anergy is lacking in T cells from lpr mice (32) and costimulation of CD95 and the TCR can inhibit release of inositoltrisphosphate in human lymphoblasts (33) . In the study performed by Kovacs and Tsokos (33) , store-operated Ca 2ϩ entry activated by TG was not inhibited by CD95 crosslink- ing, but ␣-CD3-induced Ca 2ϩ entry was reduced; however, Ca 2ϩ release was not clearly separated from influx and Ca 2ϩ assays were not calibrated. By using store depletion in Ca 2ϩ -free conditions with subsequent readdition of Ca 2ϩ , we observed a block of store-operated Ca 2ϩ entry in human T lymphoblasts after CD95 stimulation. Although our data do not exclude additional effects of CD95 on TCR signals upstream of the Ca 2ϩ store, the rescue of TCR-stimulated IL-2 synthesis by raising [Ca 2ϩ ] i with ionomycin demonstrates that the block of CRAC is sufficient for inhibition of Ca 2ϩ -dependent TCR signals. Furthermore, the unchanged Ca 2ϩ release points to an inhibition of TCR signals by CD95 downstream of endoplasmic reticulum Ca 2ϩ stores.
CD95 is an important suppressor of the immune response and has so far been thought to act by the induction of lymphocyte apoptosis. Rejection of transplanted melanoma cells is increased in lpr compared with gld mice (9), and transplanted testicular tissue from gld mice is rejected more rapidly than wild-type tissue (34) , indicating a role of CD95 for immune tolerance to transplanted malignant and normal cells. The block of Ca 2ϩ channels via CD95 could account for observations implying CD95-mediated impairment of lymphocyte function. Mice inoculated with a CD95L-expressing tumor show CD95-mediated defects in T and B lymphocyte function (14) . Interestingly, inhibition of Ca 2ϩ signals has been observed in T lymphocytes from glioblastoma patients (12) . Our observation of CD95-induced Ca 2ϩ block may provide a molecular basis for these observations. The CD95-induced block of Ca 2ϩ signals described here could alter lymphocyte function before or even in the absence of apoptosis. Because several members of the nerve growth factor͞tumor necrosis factor receptor family share the potential to activate ASM and inhibit CRAC (30, 31) , the pathway described here may represent a general means to suppress Ca 2ϩ -dependent lymphocyte activation signals.
